Developing affordable, localized molecular tests to guide treatment decisions for breast cancer patients — bringing high clinical value diagnostics worldwide.
Our Purpose
Today, life-changing molecular diagnostics remain out of reach for millions of cancer patients due to cost, geography, and systemic barriers. Access Precision Oncology was founded to change that equation.
We are building the next generation of breast cancer diagnostic tests — designed from the ground up to be clinically powerful, locally deployable, and globally affordable.
"To ensure more cancer patients worldwide have access to affordable, localized, high clinical value molecular tests."— Mission, Access Precision Oncology, Inc.
Our Focus
Developing a molecular test specifically engineered to inform treatment decisions for breast cancer patients at any healthcare setting.
Our platform is designed for regional and local labs, eliminating the need to ship samples to distant reference centers.
Cost is engineered out of the system from day one — not an afterthought — so clinically superior testing can reach patients worldwide.
Precision oncology shouldn't be a privilege of geography. We are committed to making high-value molecular testing a global standard of care.
Early Stage
Access Precision Oncology is currently operating in stealth mode as we develop our platform. Follow-on announcements will share our science, team, and pipeline.
Connect With Us
Whether you're a potential partner, investor, or simply curious — we'd love to hear from you.
info@accessmdx.com